Ellagic acid inhibits cell proliferation, migration, and invasion in melanoma via EGFR pathway

Area of Science:

• Oncology
• Pharmacology
• Natural Products

Background:

• Melanoma is an aggressive skin cancer with limited treatment options.
• Ellagic acid (EA), a polyphenol from pomegranates, shows anti-cancer properties but its role in melanoma is unclear.

Purpose of the Study:

• To investigate the anti-cancer effects of ellagic acid (EA) on melanoma cells.
• To elucidate the mechanism of EA's action, particularly its effect on the EGFR signaling pathway.

Main Methods:

• In vitro studies using WM115 and A375 melanoma cell lines.
• In vivo experiments assessing tumor growth in mouse models.
• Analysis of key protein expressions including p-EGFR, Vimentin, and E-cadherin.

Main Results:

• EA significantly inhibited melanoma cell proliferation, migration, and invasion.
• EA decreased p-EGFR and Vimentin expression while increasing E-cadherin.
• EGFR activation diminished EA's anti-cancer effects.
• EA impaired melanoma tumor growth in vivo.
• Elevated pEGFR expression correlated with poor prognosis in melanoma patients.

Conclusions:

• Ellagic acid exerts anti-cancer effects on melanoma cells by inhibiting proliferation, migration, and invasion.
• The EGFR signaling pathway is a key mediator of EA's therapeutic effects in melanoma.
• EA demonstrates potential as a novel therapeutic strategy for melanoma treatment.